Automated description from the Alliance of Genome Resources
Predicted to be involved in negative regulation of proteasomal protein catabolic process and negative regulation of protein binding activity. Predicted to localize to the nucleus. Is expressed in several structures, including central nervous system; nasal cavity epithelium; submandibular gland primordium; thymus primordium; and tooth. Orthologous to human PSME3IP1 (proteasome activator subunit 3 interacting protein 1).